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Introduction: To evaluate clinical outcomes with PDD as compared with patients who
underwent to standard physiotherapy intervention.
Material and methods: One-hundred-seventy-seven randomly assigned patients with primari-
ly radicular pain associated with a single-level lumbar contained disc herniation were
enrolled. Participants received either PDD (89 patients) or conservative physiotherapy care
(88 patients).
Results: Patients in the PDD group had signiﬁcantly greater reduction in leg pain scores and
signiﬁcantly improved VAS ( p < 0.001), Oswestry Disability Index ( p < 0.05), and 36-Item
Short Form, than those in the physiotherapy group at 12 months. On subset analysis,
patients achieved even better outcomes after PPD who: were younger, had a shorter period
of radiculopathy, of male gender, and lower BMI. Patients with subacute pain reported better
outcomes than those with chronic pain in the PDD group.
Conclusions: Patient selection for PDD over physiotherapy favored younger patients who
presented with a shorter period of pain symptoms and who had a more favorable body
habitus.
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Low back pain is the world's number one cause of disability
and one of the most prevalent health conditions [1]. Most
patients also report radicular syndromes [2]. International
guidelines provide recommendations on effective treatments
for low back pain, starting with conservative or non-surgical
treatment [3]. However, a considerable proportion of patients
with lumbar disc herniations remain symptomatic even after
undergoing conservative treatments. Epidemiological studies
have shown that the rate of persistent sciatica is 1.6% in a
given population [4] while this rate increases to 25% with aging
up to 64 years [5].
For patients who respond poorly to conservative treatment,
surgical treatment may be considered [6]. The optimal timing
for surgical intervention is not known [7]. Over the past
decade, much effort has been made for minimization in spinal
surgery [8,9]. To this end, a minimally invasive technique has
been developed to decrease intradiscal pressure through a
percutaneously inserted device placed directly into the
intervertebral discs. Several observational studies [9–12] have
been performed to assess the safety and clinical outcome of
the PDD procedure in the lumbar spine for radiculopathy [13].
One prospective, randomized, controlled lumbar was identi-
ﬁed [13]. The use of PDD technology to treat lumbar
radiculopathy due to a contained disc herniation is not well
supported currently by high-level evidence [10–12,14]. Pro-
spective randomized clinical trials with are required to
conﬁrm efﬁcacy [10,11]. The aim of this prospective random-
ized controlled clinical investigation was to compare the
clinical outcomes of patients with symptomatic lumbar disc
herniation who were treated using either conservative therapy
or the PDD procedure. A secondary goal was to better
understand the appropriate patient for this procedure.
2. Materials and methods
The study was designed as a prospective single-blinded
randomized controlled trial and was performed between
November 2010 and March 2012. It included 177 patients with
lumbosacral radicular syndrome in two groups, 89 patients who
underwent percutaneous disc decompression using the PDD
technique and 88 patients who underwent conservative
treatment.
2.1. Study protocol
This trial was approved by the local Ethical Review Committee
(No. B38). The protocol was registered with the university
committee Trials Registry, number (IUMS-B39). Necessary
precautions to protect the privacy of patients participating
in this study were considered. The study was carried out
according to the principles of the declaration of Helsinki.
2.2. Patients
All patients were selected consecutively from the University
Hospital of Qazvin (Shahid Rajaee Hospital, Qazvin). Eligiblepatients included the following: age between 18 and 70 years,
had normal neurological function, diagnosis of lumbosacral
radicular syndrome by an attending neurologist (MN) (a chief
complaint of leg pain, a positive straight leg raising (SLR) at less
than 60 degrees reproducing the leg pain, radicular pain score of
50 or greater as measured using a 0- to 100-mm VAS; and had an
ipsilateral MRI conﬁrmed disc herniation), contained disc
herniation <6 mm, with a disc height >50% [15]. All patients
who underwent percutaneous disc decompression using PDD or
conservative treatment must previously have ﬁrst conservative
treatment for the same symptoms for at least 6 weeks up to 6
months. Patients may have experienced partial pain relief with
residual symptoms, temporal pain relief or no response to the
previously conservative treatment to be included in this trail.
Patients were excluded from the study for the following
reasons: patients with more severe axial (back) pain than
radicular (leg) pain, sciatica emerging from more than one disc
level, clinical evidence of cauda eqina syndrome, severe
neurological deﬁcits, history of previously operated segments
at or directly adjacent to the level to be treated, radiological
evidence of spinal stenosis or spondylolisthesis at the level to
be treated, acute osteomyelitis, spinal tumors, suspected or
planned pregnancy within the study time period, uncontrolled
psychological disorders, and ongoing treatment for drug or
alcohol abuse. All patients with low back pain who were
eligible to be included in the study were offered participation.
Conﬁrming patient eligibility was performed by three
independent GPs (i.e. independent researchers). The GPs
(as outcome assessors) were blinded to the randomization.
2.3. Procedures
A statistician not involved in data collection or analysis
developed a randomization schedule and produced 177
consecutively numbered sealed opaque envelopes containing
each participant's allocation. Randomization was performed
using a computer-generated random allocations sequence.
The eligible patients who gave their consent were asked to
participate in a session. During this session, the nature of this
study was explained to all subjects along with an opportunity
to ask questions and decide whether or not they wanted to
participate. Informed consent was obtained from all patients
who agreed to participate. All patients were asked not to tell
the outcome assessors which intervention they received and
the outcome assessors were also advised to remind the
participants not to give them this information.
Patients were followed at baseline, 1 month, 3 months and
12 months after enrollment. Immediately after collecting
baseline data by the same initial GP the allocation envelope
was opened by a blinded researcher who guides the patients
into one of the two groups. 177 patients were randomly assigned
into PDD group (n = 89) and conservative group (n = 88).
2.4. Intervention
The percutaneous disc decompression procedure was per-
formed by a single neurosurgeon (MN) under sterile conditions
in the lateral position from the side of predominant pain using
ﬂuoroscopic guidance under moderate sedation, following the
manufacturer's instructions. Daily activity after PDD was
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 4 – 3 026restricted in the following way: for the ﬁrst 3 days sitting and
walking was limited to up to 10–20 min at a time. No driving
was allowed for the ﬁrst 2 days, and lifting was limited to
3–4 kg during the ﬁrst 2 weeks.
The control group was comprised of patients who were
treated with conservative treatment alone. Conservative
treatment was aimed mainly to reduce pain and consisted of
the following activities: bed rest, active physical therapy,
education and counseling with home exercise instruction,
spinal manipulation, narcotic analgesics, muscle relaxants,
analgesics, and nonsteroidal anti-inﬂammatory local injec-
tions. Physiotherapy was administered by seven experienced
physiotherapists at 5 private clinics and consisted of 20 sessions
per patient over the course of 12 weeks. The physiotherapy
stopped if the patients recovered before estimated session.
Following best clinical practice, the physiotherapy treatments
were diverse from patients to other patients as each patient
received a physiotherapy treatment which was appropriate for
the individual clinical presentations. All physiotherapists had
Master of Physical Therapy (MPT) and had worked frequently on
patients with low back pain and spinal disorders in their private
clinics. This non-operative treatment is considered as usual
care for patients with lumbar disc herniation [16].
All patients received a reminder call and diary cards
on which to record any side-effects during the follow-up
assessments. Patients in both treatment groups were allowedAssessed for eligibility
N=220
Enrollment
N=177
Baseline assessment 
4 lost  to  follow-
up 
89 patie nts 
assigned PDD 
treatment   
All available  data  were  an alyzed: Intent ion  t 
Fig. 1 – Flowchart of patient rto receive additional narcotic analgesics, or NSAIDs, at the
discretion of the treating GP, who recorded the medication in the
patients' records. An independent researcher who was not
involved into treatment study analysis and data collection
monitored the conservative treatment sessions to ensure that
all patients adhere to the treatment.
2.5. Study measures
The primary outcomes of the study were changes in disability
index and pain while the secondary outcome was changes in
quality of life at baseline, 1 month, 3 months and 12 months
after initial enrollment.
A self-reported questionnaire was used to collect socio-
demographic variables including age, gender, work status and
current smoking status. Furthermore, herniation level, dura-
tion of radicular pain, the previously treatment and BMI were
taken from patients' records.
2.5.1. Oswestry Disability Index (ODI), The Short Form-36,
Short Form McGill Pain Questionnaire (SF-MPQ)
An Iranian version of the ODI, SF-36, SF-MPQ were tested on
patients with chronic LBP. The results indicated that the ODI,
SF-36 and SF-MPQ are a reliable and valid instrument to
measure functional status in Persian-speaking patients with
LBP [16–18].88 pati ents 
assign ed 
conservative
treatment 
 5 lost to  fol low-
up
23 paents  refusing  to  parcip ate 
 20  pa ents  not  me eng inclusion  criter ia  
o treat  anal ysis 
ecruitment and dropout.
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n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 4 – 3 0 272.6. Statistical analysis
Normality of distribution for every dependent variable was
assessed with the Kolmogorov–Smirnov test and through
visual inspection of the data. An independent t test and chi
square were used to compare patients' characteristics.
A 2-way repeated-measures analysis of covariance
(ANCOVA), with group (conservative, PDD) as the between-
subjects variable, time (baseline, 1 month, 3 months and 12
months) as the within-subjects variable, and age, sex, BMI and
duration of radicular pain as covariate, was used to examine the
effects of the intervention. Between-group effect size was
calculated using Partial Eta squared. Post hoc analyses, with
Bonferroni corrections, were applied in all comparisons. An
intention-to-treat analysis was performed in comparing patient
groups.
All statistical analyses were performed by an independent
biostatistician with SPSS for Windows version 16.0. Results
were considered statistically signiﬁcant if the p-value was
equal to or less than .05 for continuous variables. For
percentage outcomes and non-parametric values, 95% conﬁ-
dence intervals were used to show statistical signiﬁcance.
3. Results
This study included 177 subjects: 89 in the percutaneous disc
decompression (PDD) group and 88 in the conservative care
(CC) group. After 12 months, nine patients (5.1% of the overall
patients studied) dropped out of the study, four in the PDD
group and ﬁve in the conservative group (Fig. 1). Most
participants in this study were female. All patients ranged
from 20 to 70 years of age. Clinical and sociodemographic
variables were comparable in both groups (Table 1). AtTable 1 – Sample characteristics.
Characteristic Conservative
treatment
N = 88
PDD
N = 89
P value
Mean, SD
Age-years 38.02 (8.99) 37.57 (7.26) 0.73
Employment status
Full time or part time 34 (38.6%) 25 (28.1%)
Housekeeper 20 (22.7%) 27 (30.3%)
Unemployed 34 (38.6%) 37 (41.6%) 0.28
Sex
Male 43 (48.9%) 36 (40.4%)
Female 45 (51.1%) 53 (59.6%) 0.16
Current smoking status
Yes 56 (63.6%) 54 (60.7%)
No 32 (36.4%) 35 (39.3%) 0.40
Mean BMI Kg/m2 25.40 (4.15) 26.12 (4.53) 0.77
Duration of radicular
pain (months)
25.91 (8.63) 18.64 (12.04) 0.46
Herniation level 0.602
L2–L3 3 (3.4%) 6 (6.7%)
L3–L4 19 (21.6%) 15 (16.9%)
L4–L5 21 (23.9%) 25 (28.1%)
L5–S1 45 (51.1%) 43 (48.3%) T
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Table 4 – Covariates associated with the quality of life across time.
Age Gender
(male vs. female)
BMI Pain duration
(sub-acute vs. chronic)
F P hp
2 F P hp
2 F P hp
2 F P hp
2
PF 2.76 0.04 0.016 2.47 0.02 0.02 0.861 0.035 0.005 3.09 0.02 0.018
RP 1.47 0.22 0.009 0.72 0.53 0.004 0.255 0.858 0.001 0.451 0.71 0.003
BP 2.59 0.04 0.020 0.219 0.88 0.001 0.26 0.61 0.002 3.60 0.01 0.021
GH 0.59 0.44 0.003 3.08 0.02 0.018 0.582 0.62 0.003 1.66 0.173 0.010
VT 2.69 0.04 0.016 0.28 0.83 0.002 0.73 0.53 0.004 0.24 0.86 0.001
SF 0.50 0.68 0.003 0.68 0.56 0.004 0.74 0.52 0.004 0.59 0.62 0.003
RE 1.263 0.286 0.007 0.972 0.40 0.006 0.436 0.73 0.003 2.610 0.04 0.015
MH 0.183 0.90 0.001 0.252 0.86 0.001 0.43 0.72 0.003 5.31 0.001 0.030
PCS 5.13 0.001 0.030 0.437 0.72 0.003 0.252 0.860 0.001 5.26 0.001 0.030
MCS 0.872 0.455 0.005 1.42 0.23 0.008 0.708 0.54 0.004 3.351 0.019 0.02
Table 3 – Covariates associated with the pain and disability across time.
Age Gender
(male vs. female)
BMI Pain duration
(sub-acute vs. chronic)
F P hp
2 F P hp
2 F P hp
2 F P hp
2
VAS scores 4.37 0.005 0.073 4.58 0.03 0.02 9.23 0.001 0.03 3.32 0.02 0.02
Present pain intensity 4.82 0.005 0.025 3.83 0.008 0.02 4.21 0.03 0.024 4.41 0.004 0.03
Sensory 13.13 0.001 0.07 2.29 0.03 0.02 3.57 0.01 0.02 1.39 0.24 0.008
Affective 5.79 0.001 0.04 5.90 0.001 0.03 2.59 0.04 0.02 4.32 0.013 0.025
Total 9.94 0.001 0.06 3.85 0.01 0.02 4.33 0.04 0.025 13.83 0.001 0.08
ODI 2.73 0.04 0.016 11.01 0.001 0.063 2.89 0.035 0.02 4.63 0.033 0.027
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 4 – 3 028baseline, no signiﬁcant differences were observed in clinical
and sociodemographic variables between the two groups.
An ANCOVA was conducted to examine mean-level group
differences in VAS across times. The results indicated that
the VAS was reduced signiﬁcantly across times in both groups
(p < 0.05). Furthermore, there was a signiﬁcant difference in
VAS between the two groups as patients who received PDD
treatment reported lower VAS score than those undergoing
conservative treatment (p < 0.001). Distinct reductions in pain
intensity, sensory, affective and total pain all were observed
for patients who received PDD treatment (Table 2).
Concerning disability, as assessed by the ODI, repeated
measure ANCOVA revealed a signiﬁcant time  group inter-
action for ODI [F (1,171) = 11.52, p < 0.05]. Bonferroni post hoc
analysis revealed that patients in the PDD group report
signiﬁcantly lower disability than those undergoing conserva-
tive treatment.
Looking for the ideal patient selection for the PDD
procedure, better results were found in younger patients
and those with a short period of radicular pain. Furthermore,
being of male gender and lower BMI were also associated with
better outcomes including VAS, quality of life and ODI (Tables
3 and 4). In addition to this, patients with sub-acute (i.e. 6
weeks to 3 months) pain reported better outcomes compared
to those with pain of chronic duration (Tables 3 and 4).
Differences in health-related quality of life were observed
during follow-up between the two groups (Table 5). Physically
based subscales of the SF-36 reduced signiﬁcantly in both
groups across times (Table 5). However, no signiﬁcant reduced
change was seen for mental based subscales of the SF-36 for
either group across times. PCS rose from baseline to 12 monthsin subjects who received PDD (Group  time interaction:
F = 3.36, p = .01).
There were no major complications related to the PDD
procedure. Speciﬁcally, there were no cases of infection or
nerve root injury. No signiﬁcant clinical adverse events were
observed in this study with the exception of minor local
anesthetic-related side effects.
4. Discussion
In this study we directly compare nucleoplasty, a percutane-
ous PDD technique, to conservative treatment for patients
with symptomatic lumbar disc herniations. The PDD proce-
dure as well as conservative treatment both gave clinically
useful effects on the primary outcome of VAS and disability.
Findings from the secondary analyses support the primary
analyses, showing signiﬁcant positive effects on health-
related quality of life especially in physically based SF-36
subscales but not for mental based subscales of the SF-36 at 1, 3
or 12 months. However, the PDD group had signiﬁcantly a
greater reduction of pain scores as well as better SF-36 and ODI
results than the conservative group [9]. We found especially
young patients and patients with a short period of radicular
pain experienced better post-interventional results [19]. Other
studies could also show better results in patients with a short
duration of symptoms but they could not ﬁnd the gender, BMI
and age effect [20].
So far to date several observational studies of limited to fair
quality have shown that the PDD procedure is a possibly
effective treatment in managing radicular pain for patients
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n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 4 – 3 0 29with ipsilateral contained disc herniation who are refractory to
conservative therapy [9–11,21]. To the best of our knowledge,
this is the ﬁrst randomized controlled trail looking for PDD
versus conservative treatment in patients complaining of
primarily leg pain [11,22]. Conservative treatment was chosen
to be the control group, as this is the ﬁrst treatment option in
patients with refractory sciatica with or without back pain. So
we compared the PDD procedure results with a group who
received optimal care [22,23]. While all patients were random-
ized to treatment groups due to the nature of the different
interventions in both groups it was not possible to blind
participants and healthcare providers from knowledge of
which intervention a participant received. Although the lack of
blinding might be considered as a weakness in the study
design, we tried to reduce this risk of bias, as all patients were
treated according to a strict protocol.
Furthermore the outcome assessors were blinded from
knowledge of which intervention a participant received.
Inclusion criteria speciﬁed that all participants had to have
a failed conservative treatment, which may had the possibility
to bias the study in favor of PDD method. Our results support
the literature that PDD is a safe procedure [11,24], as the
complication rate for lumbar nucleoplasty was 1.8% [9].
As the inclusion criteria for all patients in the nucleoplasty
group was to have failed conservative treatment, this could
have led to a bias against the PDD group, as those patients
experienced a signiﬁcantly longer duration pain symptoms.
Furthermore, the PDD group has a higher VAS score and pain
intensity at baseline.
Gerszten et al. could show in a randomized controlled
clinical trail the superiority of PDD intervention over trans-
formational epidural steroid injection in patients with an
initial failed treatment of epidural steroid injections [13]. In our
study functional capacity, measured via ODI, increased
according to baseline and in comparison to conservative
treatment. This is similar to the results of other studies [13,24].
Different studies have shown that conservative treatment,
including epidural steroid injection, is known not to have a
pain reducing long-term effect [25]. This might explain why
Eichen et al. could not ﬁnd a conservative pain reduction effect
in compression alone compared to baseline [9]. The VAS/NPS
reduction for lumbar nucleoplasty was demonstrated to be
superior to conservative therapy within the ﬁrst 3 months [9].
The results of this investigation also show a signiﬁcant VAS
superiority at 12 months.
5. Conclusion
Lumbar PDD is a minimally invasive safe procedure, being able
to increase functional mobility and reduce leg pain in a long
term follow-up in patients with symptomatic contained
lumbar disc herniations. It appears to be most effective for
younger patients with relatively short duration of pain
symptoms.
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